NY Activists Vow to Improve Stalled CBD and Hemp Bill

November 22, 2019 09:00:01

The 2018 Hemp Farming Act was a godsend for the hemp industry. The legislation classified cannabis with less than 0.3 percent THC as hemp and removed it from its list of controlled substances. Dubbed by some as a catalyst for explosive growth, the bill gave farmers in all 50 states leeway to grow the versatile cash crop under regulation.

Six months later in June 2019, the New York Assembly passed the state’s own Hemp Extract Bill. The bill would have allowed licensed retailers to add up to 20mg of CBD per twelve ounces beverage. However, several months later, the bill still languishes on Governor Andrew Cuomo’s desk, awaiting his approval.

As the New York hemp industry remains in a state of uncertainty, a group of industry insiders is looking to have the bill approved as soon as possible. Jonathan Miller, a lawyer for the U.S. Hemp Roundtable says Governor Cuomo is expected to issue a ‘friendly veto’ of the bill, which will allow it to be reintroduced during the budget process next year. “He likes the bill but is expected to veto it so we can improve it for the next session.”

However, without concrete regulations, the industry quickly filled up with sellers whose products promise untold benefits. A lot of the unregulated products contain different levels of cannabinoids promised on the labels and other contaminants. To ensure consumer safety, the New York State Department of Health and Agriculture stepped in, but in the process, sellers maintaining high product quality have also been affected.

At the moment, CBD can only be sold in the State as a dietary supplement. According to Joy Beckerman, President of the Hemp Industries Association, the organization would like to see three key issues addressed when the hemp bill is reintroduced. First, looser licensing requirements for manufacturers and sellers, capped fees for growers and producers, and lastly, to open up the New York hemp market to growers and processors from other states.

She says that what the organization desires is “better protection for small New York farms and businesses to be able to enter the hemp economy and take advantage of these new opportunities.” According to Karlan Castetter, a New York hemp producer and the CEO of Castetter Sustainability Group, developing a transparent and consistent supply chain and listing the region where the plants are grown is important. “We don’t want imported hemp that’s full of contaminants. All that it takes is a couple of bad products.”

Castetter says that although the June 2019 bill was a little restrictive, it was a step toward ensuring the New York hemp sector isn’t left behind by other states. “We don’t have three or four years. This market is moving very quickly, so we need to get ahead of that now.”

Experts think CBD players, such as Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) and Neutra Corp. (OTC: NTRR) are happy that new life is going to be breathed into New York State’s CBD law.

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

Denver, Colorado
303.498.7722 Office

CBDWire is part of the InvestorBrandNetwork.